According to Reuters a group of three non-profits, including a California nonprofit organization, has filed papers suing fish oil manufacturers and pharmacies that sell the popular supplement, fish oil. They the manufacturers and pharmacies did not properly disclose the toxicity of the fish oil. The legal claim, filed Tuesday in a San Francisco Superior Court, [...]
The House Committee on Oversight and Government Reform, chaired by Congressman Edolphus Towns, will hold a hearing entitled: “Prostate Cancer: New Questions About Screening and Treatment” tomorrow, Thursday, March 4, 2010 at 10:00 a.m. This is the first Congressional prostate cancer hearing in 11 years and, in the midst of debate on a health reform [...]
Currently, there is “Dear Colleague Letter” being circulated by two members of the U.S. House of Representatives, Jim Marshall (GA) and Peter King (NY) asking for support for increased funding for the Prostate Cancer Research Program (PCRP) — part of the Congressionally Directed Medical Research Program at the Department of Defense. The letters are circulated [...]
We know that docetaxel chemotherapy (chemo) extends life, but which men might hope to experience an increase in survival? The Department of Urology, All India Institute of Medical Sciences, New Delhi, India performed a small study designed to evaluate the efficacy of docetaxel/prednisone and zoledronic acid in the treatment of men with hormone refractory prostate [...]
In a Town Hall discussion, “Ablating Testosterone in Prostate Cancer and the Concomitant Negative Effects”, Fred Saad, MD, FRCS, Director of Urologic Oncology, Professor of Surgery/Urology, U of M Chair in Prostate Cancer; University of Montreal discussed the negative effects that bone loss resulting from hormone therapy (ADT) poses to our life expectancy. His over [...]